Outcomes at 2 Years of Age after Repeat Doses of Antenatal Corticosteroids

Crowther, Caroline A., Doyle, Lex W., Haslam, Ross R., Hiller, Janet E., Harding, Jane E., Robinson, Jeffrey S., Ashwood, P., Paynter, J., Holst, C., Robinson, K., Willson, K., Lumley, J., Carlin, J., Carse, E., Ratnapala, M., Hanafy, A., Reid, R., Austin, N., Darlow, B., Hunter, J., Liley, H., Mogridge, N., Poad, D., Broadbent, R., Gillies, K., Patel, F., Tout, S., Wilson, D., Ludwig, D., Carman, G., Ende, K., Heininger, J., Tan, F., Van der Westhuyzen, J., Giles, W., Gill, A., Miljkovic, L., Nicoll, A., O’Callaghan, S., Vimpani, A., Chan, F., Flenady, V., Cincotta, R., Gray, P., Hegarty, J., Jenkins-Manning, S., Lewis, L., Liley, H., Poulsen, L., Rogers, Y., Toohill, J., Tudehope, D., Woodgate, P., Mildenhall, L., Brown, I., Hayward, L., Smith, D.W., Thesing, A., Wadsworth, S., Burrows, R., Charlton, M., Hayes, M., Taylor, N., Yu, V., McCowan, L., Taylor, R., Bevan, C., Aftimos, S., Alsweiler, J., Armstrong, D., Battin, M., Dezoete, J.A., Light, M., Stone, P., Thesing, A., Webster, N., West, C., Kuschel, C., Gillies, K., Bates, G., Baillie, D., Hastings, L., Jory, A., Mercer, P., Pullen, R., Scott, G., Bury, G., Bacic, S., Butterley, K., Giannaros, H., Jarrell, S., Standen, G., Fisher, C., Challis, D., Asgill, K., Buist, R., Cameron, D., Dyer, K., Lui, K., Milner, S., Sutton, L., Woodhart, L., Morris, J., Bowen, J., Gallimore, V., Gibson, F., Leslie, G., Maher, C., Child, A., Henderson-Smart, D., Jeffery, H., Ogle, R., Osborn, D., Peat, B., Phipps, H., Polverino, J., Rieger, I., Vaughan, J., Wocadlo, C., Colditz, P., Allen, R., de Dassel, T., Fitzsimmons, T., Horn, J., Katterns, W., Pritchard, M., Smith-Orr, V., Somville, T., Wilson, J., Wilson, M., Reynolds, G., Downes, P., Ellwood, D., Hand, P., Jacob, E., Lindgren, J., Nugent, J., Peek, M., Ringland, C., Rollason, C., Watkins, A., Fraser, S., Wein, P., Higgins, J., Kelly, E., Keng, J., McCarthy, E., Turner, A., Walker, S., Woods, H., Brennecke, S., Callanan, C., Davis, N., Ford, G., Howard, K., Kelly, E., Kornman, L., Lim, M., McGrath, G., Rushford, D., Watson, D., Blair, A., Campbell, S., Dederer, A., Green, E., Lawrence, A., Roberts, G., Roberts, K., Whitehall, J., Ratnapala, M., Chadha, Y., Gibson, E.D., Morris, B., Bourchier, D., Haslam, A., Holmes, C., McLaughlin, R., Meher-Homji, N., Reetz, J., Weston, P., Sangalli, M., Bedford, N., Calvert, S., Coles, C., Corbett, G., Elder, D., Preston, U., Richardson, V., Barnett, C., Bhatia, V., Coppinger, V., Deussen, A., Dodd, J., Fitzgerald, J., Gibbons, S., Griffith, E., Harris, K., Headley, B., Holst, C., Khong, T.Y., Lioulios, E., McLaughlin, K., McPhee, A., O’Grady, M., Paine, B., Paynter, J., Ramsay, J., Robinson, K., Russell, S., Santich, M., Vigneswaren, R., and Zhang, L. (2007) Outcomes at 2 Years of Age after Repeat Doses of Antenatal Corticosteroids. New England Journal of Medicine, 357 (12). pp. 1179-1189.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: http://dx.doi.org/10.1056/NEJMoa071152
 
179
7


Abstract

Background: We previously reported the results of a randomized, controlled trial showing that repeat doses of antenatal corticosteroids reduced the risk of respiratory distress syndrome and serious neonatal morbidity. However, data have not been available regarding longer-term effects of this treatment.

Methods: Women who had received an initial course of corticosteroid treatment 7 or more days previously were randomly assigned to receive an intramuscular injection of corticosteroid (11.4 mg of betamethasone) or saline placebo; the dose was repeated weekly if the mother was still considered to be at risk for preterm delivery and the duration of gestation was less than 32 weeks. We assessed survival free of major neurosensory disability and body size of the children at 2 years of corrected age.

Results: Of the 1085 children who were alive at 2 years of age, 1047 (96.5%) were seen for assessment (521 exposed to repeat-corticosteroid treatment and 526 exposed to placebo). The rate of survival free of major disability was similar in the repeatcorticosteroid and placebo groups (84.4% and 81.0%, respectively; adjusted relative risk, 1.04, 95% confidence interval, 0.98 to 1.10; adjusted P = 0.20). There were no significant differences between the groups in body size, blood pressure, use of health services, respiratory morbidity, or child behavior scores, although children exposed to repeat doses of corticosteroids were more likely than those exposed to placebo to warrant assessment for attention problems (P = 0.04).

Conclusion: Administration of repeat doses of antenatal corticosteroids reduces neonatal morbidity without changing either survival free of major neurosensory disability or body size at 2 years of age.

Item ID: 33685
Item Type: Article (Refereed Research - C1)
ISSN: 1533-4406
Funders: National Health and Medical Research Council of Australia (NHMRC), Channel 7 Research Foundation, South Australia, Women's and Children's Hospital Foundation, Adelaide, University of Adelaide
Projects and Grants: NHMRC 157915, NHMRC 349459
Date Deposited: 14 Oct 2014 00:07
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1114 Paediatrics and Reproductive Medicine > 111402 Obstetrics and Gynaecology @ 100%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920114 Reproductive System and Disorders @ 100%
Downloads: Total: 7
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page